recurrent primary peritoneal serous adenocarcinoma
Showing 1 - 2 of 2
Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in
Not yet recruiting
- Ovarian Clear Cell Adenocarcinoma
- +14 more
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140
- +4 more
-
Buffalo, New York
- +1 more
Dec 16, 2022
Borderline Ovarian Serous Tumor, Micropapillary Serous Carcinoma, Ovarian Serous Adenocarcinoma Trial in United Kingdom, United
Active, not recruiting
- Borderline Ovarian Serous Tumor
- +5 more
- Letrozole
- +7 more
-
Huntsville, Alabama
- +507 more
Dec 27, 2021